Dow Inc. (DOW) Laps the Stock Market: Here's Why

Dow Inc. (DOW) closed up 1.23% at $27.15, outperforming the broader market, yet faces a challenging outlook ahead of its July 24, 2025 earnings announcement. Analysts project a quarterly EPS of -$0.02, a 102.94% downward movement from the prior year, and revenue of $10.35 billion, down 5.2%; annual forecasts also indicate significant declines. The materials science company currently holds a Zacks Rank #4 (Sell) due to recent negative analyst estimate revisions, and trades at a premium Forward P/E of 70.77 and PEG of 8.09, substantially above its industry averages, with its Chemical - Diversified sector ranking in the bottom 9% of all industries.

Analysis

Despite a recent single-day stock price increase of 1.23% to $27.15, which outpaced the broader market, Dow Inc. (DOW) faces a significantly deteriorating fundamental outlook. Over the past month, the stock has underperformed, lagging the S&P 500 by over 10 percentage points. The consensus forecast for its upcoming earnings on July 24, 2025, points to a quarterly EPS of -$0.02, representing a 102.94% year-over-year decline, and a 5.2% drop in revenue to $10.35 billion. This negative trend extends to the full-year outlook, with anticipated contractions of 77.78% in earnings and 3.02% in revenue. Reflecting this pessimism, the Zacks Consensus EPS estimate has been revised downward by 12.91% in the last month, earning the stock a Zacks Rank of #4 (Sell). Compounding these concerns, the company's valuation appears stretched, with a Forward P/E ratio of 70.77 and a PEG ratio of 8.09, both substantially premium to the industry averages of 14.24 and 1.93, respectively. This weakness is contextualized by broad-based sector headwinds, as the Chemical - Diversified industry ranks in the bottom 9% of over 250 industries.

Key Decisions for Investors

• Investors should view the recent single-day stock gain with caution, as it runs contrary to the deeply negative underlying fundamentals and a month-long trend of underperformance.
• The stock's high valuation, evidenced by a Forward P/E of 70.77 and a PEG ratio of 8.09, presents a significant risk, as it suggests the price is disconnected from the sharply declining earnings forecasts.
• Ahead of the July 24, 2025, earnings report, it is critical to monitor for any deviation from the projected 102.94% EPS drop and to scrutinize management's guidance for signs of either stabilization or further decline.
• Given the stock's Zacks #4 (Sell) rating and its industry's ranking in the bottom 9%, positions should be evaluated in the context of sector-wide cyclical headwinds, not just company-specific performance.